Werke Healthcare
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Glumight MV 1mg/500mg/0.3mg Tablet is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults.
Tablet
Glumight MV 1mg/500mg/0.3mg Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glumight MV 1mg/500mg/0.3mg Tablet is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Glumight MV 1mg/500mg/0.3mg Tablet.
Glumight MV 1mg/500mg/0.3mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Glumight MV 1mg/500mg/0.3mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Glumight MV 1mg/500mg/0.3mg Tablet is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain loss of appetite or yellowing of the eyes or skin (jaundice).
Glumight MV 1mg/500mg/0.3mg Tablet is a combination of three medicines: Glimepiride, Metformin and Voglibose. This medicine is used in the treatment of type 2 diabetes mellitus (DM). It improves blood glucose levels in adults when taken along with proper diet and regular exercise. Glimepiride lowers blood glucose by increasing insulin release from the pancreas. Metformin works by lowering glucose production in the liver and improving insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor that lowers postprandial (after meals) glucose levels. This combination is not indicated for the treatment of Type 1 DM.
Possible side effects include hypoglycemia (low blood sugar level), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infection. If a person experiences any of these reactions it is important to contact their doctor immediately.
Glumight MV 1mg/500mg/0.3mg Tablet must not be used in patients with known allergy to any of the components or excipients of this medicine. It is also not indicated for use in patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations and underlying metabolic acidosis including diabetic ketoacidosis.
No, alcohol should not be taken along with Glumight MV 1mg/500mg/0.3mg Tablet as it may lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Yes, Glumight MV 1mg/500mg/0.3mg Tablet can cause hypoglycemia (low blood sugar level). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate and feeling anxious or shaky. This is more likely to occur when food is missed or delayed, alcohol consumed, over-exertion or other antidiabetic medicines are used simultaneously with the medication. Regular monitoring of blood sugar levels is essential. It is advisable to keep glucose tablets, honey, or fruit juice readily accessible.
Store this medicine in its original container or pack, tightly closed. Follow the instructions on the packaging label for storage. Dispose of unused medication responsibly, ensuring pets, children, and others do not access it.